Q4 Earnings Highlights Sotera Health Company Vs The Rest Of The Research Tools Consumables Stocks
| TECH Stock | USD 62.16 2.28 3.81% |
Under 55% of Bio Techne's traders are presently thinking to get in. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that some investors are interested at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.
Bio |
Looking back on research tools consumables stocks Q4 earnings, we examine this quarters best and worst performers, including Sotera Health Company and its peers.
Read at finance.yahoo.com
 |
Bio Techne Fundamental Analysis
We analyze Bio Techne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Bio Techne is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bio Techne Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Techne stock to make a market-neutral strategy. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with similar companies.
Peers
Bio Techne Related Equities
| NUVL | Nuvalent | 3.40 | ||||
| TVTX | Travere Therapeutics | 3.14 | ||||
| LQDA | Liquidia Technologies | 2.85 | ||||
| HALO | Halozyme Therapeutics | 1.98 | ||||
| PCVX | Vaxcyte | 1.85 | ||||
| VTYX | Ventyx Biosciences | 1.44 | ||||
| APLS | Apellis Pharmaceuticals | 1.19 | ||||
| UTHR | United Therapeutics | 0.61 | ||||
| ASND | Ascendis Pharma | 0.44 | ||||
| ALNY | Alnylam Pharmaceuticals | 0 | ||||
| BPMC | Blueprint Medicines | 0.29 | ||||
| EXEL | Exelixis | 0.41 | ||||
| AKRO | Akero Therapeutics | 1.58 | ||||
| BMRN | Biomarin Pharmaceutical | 1.64 | ||||
| REPL | Replimune | 1.69 | ||||
| LEGN | Legend Biotech | 2.23 |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |